Frontiers in Aging Neuroscience

Papers
(The H4-Index of Frontiers in Aging Neuroscience is 47. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Mitochondrial Dysfunction and Oxidative Stress in Alzheimer’s Disease231
Microglia Polarization From M1 to M2 in Neurodegenerative Diseases215
Machine Learning for the Diagnosis of Parkinson's Disease: A Review of Literature151
Brain Microvascular Pericytes in Vascular Cognitive Impairment and Dementia137
Comprehensive Evaluation of the 5XFAD Mouse Model for Preclinical Testing Applications: A MODEL-AD Study134
Cellular Senescence in Brain Aging127
Cognitive and Neuropsychiatric Manifestations of COVID-19 and Effects on Elderly Individuals With Dementia123
Cholesterol and Alzheimer’s Disease; From Risk Genes to Pathological Effects108
The Association Between the Gut Microbiota and Parkinson's Disease, a Meta-Analysis108
The Impact of Disease Comorbidities in Alzheimer's Disease107
Global, regional, and national burden of Alzheimer's disease and other dementias, 1990–2019103
Impact of Anti-amyloid-β Monoclonal Antibodies on the Pathology and Clinical Profile of Alzheimer’s Disease: A Focus on Aducanumab and Lecanemab96
The NLRP3 Inflammasome Pathway: A Review of Mechanisms and Inhibitors for the Treatment of Inflammatory Diseases96
Mitochondrial Dysfunction and Alzheimer’s Disease: Role of Microglia95
Aging and Neurodegenerative Disease: Is the Adaptive Immune System a Friend or Foe?81
Astrocyte Senescence and Alzheimer’s Disease: A Review80
APOE Alleles and Diet in Brain Aging and Alzheimer’s Disease80
Interleukin-17A: The Key Cytokine in Neurodegenerative Diseases79
Functional Aging in Male C57BL/6J Mice Across the Life-Span: A Systematic Behavioral Analysis of Motor, Emotional, and Memory Function to Define an Aging Phenotype78
Resveratrol Derivatives as Potential Treatments for Alzheimer’s and Parkinson’s Disease77
The Impact of COVID-19 Quarantine on Patients With Dementia and Family Caregivers: A Nation-Wide Survey77
Mechanisms of Pathogenic Tau and Aβ Protein Spreading in Alzheimer’s Disease75
Astroglia and Tau: New Perspectives69
The Biology and Pathobiology of Glutamatergic, Cholinergic, and Dopaminergic Signaling in the Aging Brain69
Roles and Mechanisms of Gut Microbiota in Patients With Alzheimer’s Disease69
Neuroimmunomodulatory and Neuroprotective Effects of the Flavonoid Apigenin in in vitro Models of Neuroinflammation Associated With Alzheimer’s Disease64
Alzheimer’s Disease: An Update and Insights Into Pathophysiology64
Glucocerebrosidase Defects as a Major Risk Factor for Parkinson’s Disease63
Mild Behavioral Impairment Is Associated With Atrophy of Entorhinal Cortex and Hippocampus in a Memory Clinic Cohort62
Age-Related Olfactory Dysfunction: Epidemiology, Pathophysiology, and Clinical Management61
The Role of Resting-State Network Functional Connectivity in Cognitive Aging61
The Gut–Brain Axis and Its Relation to Parkinson’s Disease: A Review60
Impact of COVID-19 on Mitochondrial-Based Immunity in Aging and Age-Related Diseases60
Molecular Chaperones: A Double-Edged Sword in Neurodegenerative Diseases58
Inflammation From Peripheral Organs to the Brain: How Does Systemic Inflammation Cause Neuroinflammation?56
Alpha-Synuclein as a Biomarker of Parkinson’s Disease: Good, but Not Good Enough55
Channelrhodopsin Excitation Contracts Brain Pericytes and Reduces Blood Flow in the Aging Mouse Brain in vivo55
Grip Strength and the Risk of Cognitive Decline and Dementia: A Systematic Review and Meta-Analysis of Longitudinal Cohort Studies53
Plant-Derived Antioxidants Protect the Nervous System From Aging by Inhibiting Oxidative Stress53
Prevalence of Alzheimer's Disease and Parkinson's Disease in China: An Updated Systematical Analysis52
Gut Microbiome Signatures Are Biomarkers for Cognitive Impairment in Patients With Ischemic Stroke52
Update on the Mechanism and Treatment of Sevoflurane-Induced Postoperative Cognitive Dysfunction51
Mitophagy in Cerebral Ischemia and Ischemia/Reperfusion Injury51
Past, Present, and Future of Non-invasive Brain Stimulation Approaches to Treat Cognitive Impairment in Neurodegenerative Diseases: Time for a Comprehensive Critical Review50
Nicotinamide, a Poly [ADP-Ribose] Polymerase 1 (PARP-1) Inhibitor, as an Adjunctive Therapy for the Treatment of Alzheimer’s Disease49
Detection of Mild Cognitive Impairment Using Convolutional Neural Network: Temporal-Feature Maps of Functional Near-Infrared Spectroscopy48
Heterogeneity in Regional Damage Detected by Neuroimaging and Neuropathological Studies in Older Adults With COVID-19: A Cognitive-Neuroscience Systematic Review to Inform the Long-Term Impact of the 48
Hearing Loss and Cognition: What We Know and Where We Need to Go47
The Cross-Links of Endoplasmic Reticulum Stress, Autophagy, and Neurodegeneration in Parkinson’s Disease47
0.047134876251221